Zivo Bioscience Shares Continue Volatility, Drop 14%
Zivo Bioscience Shares Continue Volatility, Drop 14%
By Chris Wack
克里斯·瓦克(Chris Wack)著
Zivo Bioscience Inc. shares dropped 14% to $4.03 in Tuesday trading, after rising 67% Monday.
Zivo Bioscience Inc.股價週二下跌14%，至4.03美元，週一上漲67%。
Volume for the stock was 2.6 million shares at 12:30 p.m. ET, compared with 65-day average volume of 2 million shares. The stock, which has a public float of 6.2 million shares, hit its 52-week low of $2.72 on Aug. 17.
截至下午12：30，該股成交量為260萬股。美國東部時間，相比之下，65天平均成交量為200萬股。該股公開流通股為620萬股，8月17日觸及2.72美元的52周低點。
Shares of Zivo ended Friday's session down 17%.
Zivo股價週五收盤下跌17%。
Chief Executive Andrew Dahl in August issued a letter to company stockholders saying that after years of stopgap funding and on-and-off research and development, the company has found itself in the strongest financial position ever, and a "portfolio with great promise and prospects."
首席執行官安德魯·達爾(Andrew Dahl)在8月份致公司股東的一封信中表示，經過多年的權宜之計和斷斷續續的研發，該公司發現自己處於有史以來最強勁的財務狀況，是一個“充滿希望和前景的投資組合”。
Write to Chris Wack at chris.wack@wsj.com
寫信給克里斯·瓦克(chris.wack@wsj.com)
譯文內容由第三人軟體翻譯。